Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 17 studies | 34% ± 12% | |
lung | 15 studies | 29% ± 13% | |
brain | 10 studies | 30% ± 13% | |
intestine | 9 studies | 26% ± 12% | |
eye | 9 studies | 26% ± 10% | |
kidney | 7 studies | 24% ± 5% | |
lymph node | 5 studies | 29% ± 6% | |
pancreas | 4 studies | 42% ± 15% | |
placenta | 4 studies | 27% ± 5% | |
bone marrow | 4 studies | 27% ± 6% | |
uterus | 4 studies | 35% ± 15% | |
breast | 4 studies | 27% ± 6% | |
liver | 4 studies | 39% ± 18% | |
prostate | 3 studies | 23% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 3398.08 | 459 / 459 | 100% | 94.03 | 1118 / 1118 |
ovary | 100% | 2958.34 | 180 / 180 | 100% | 70.70 | 430 / 430 |
pancreas | 100% | 2309.55 | 328 / 328 | 100% | 66.80 | 178 / 178 |
stomach | 100% | 2470.38 | 359 / 359 | 100% | 84.54 | 286 / 286 |
lung | 100% | 2837.16 | 578 / 578 | 100% | 84.25 | 1153 / 1155 |
brain | 100% | 3207.84 | 2636 / 2642 | 100% | 72.74 | 705 / 705 |
prostate | 100% | 2873.57 | 245 / 245 | 100% | 67.14 | 500 / 502 |
bladder | 100% | 3134.00 | 21 / 21 | 99% | 77.83 | 501 / 504 |
uterus | 100% | 3168.81 | 170 / 170 | 99% | 80.73 | 456 / 459 |
thymus | 100% | 3181.66 | 653 / 653 | 99% | 69.91 | 600 / 605 |
intestine | 100% | 3114.30 | 966 / 966 | 99% | 98.82 | 522 / 527 |
liver | 100% | 2063.02 | 226 / 226 | 99% | 48.83 | 402 / 406 |
esophagus | 100% | 2949.61 | 1445 / 1445 | 99% | 76.64 | 181 / 183 |
kidney | 100% | 2965.01 | 89 / 89 | 99% | 55.77 | 889 / 901 |
adrenal gland | 100% | 3737.75 | 258 / 258 | 98% | 65.59 | 226 / 230 |
skin | 100% | 4107.16 | 1809 / 1809 | 96% | 73.28 | 455 / 472 |
adipose | 100% | 3495.14 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3069.35 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 83.37 | 29 / 29 |
muscle | 100% | 3053.12 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2699.06 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 72.14 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 23.01 | 1 / 1 |
heart | 96% | 1965.86 | 827 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 36.29 | 70 / 80 |
peripheral blood | 77% | 2247.41 | 717 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0043547 | Biological process | positive regulation of GTPase activity |
GO_0002181 | Biological process | cytoplasmic translation |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0045296 | Molecular function | cadherin binding |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | ZC3H15 |
Protein name | Zinc finger CCCH-type containing 15 Zinc finger CCCH domain-containing protein 15 (DRG family-regulatory protein 1) (Likely ortholog of mouse immediate early response erythropoietin 4) |
Synonyms | PP730 DFRP1 HT010 MSTP012 HSPC303 LEREPO4 |
Description | FUNCTION: Protects DRG1 from proteolytic degradation . Stimulates DRG1 GTPase activity likely by increasing the affinity for the potassium ions . . |
Accessions | F8WB26 F8WF67 ENST00000437396.1 H7C466 ENST00000445547.1 ENST00000337859.11 [Q8WU90-1] Q8WU90 ENST00000421536.5 |